Clinical Trials on COVID 16 Arrhythmia in Japan
Total 180 results
-
Nidek Co. LTD.CompletedIOP Ranges(mmHg): 7 to 16, >16 to <23, and 23 or MoreJapan
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
National Cerebral and Cardiovascular CenterRecruiting
-
SanofiCompletedVentricular Arrhythmia | Arrhythmia ProphylaxisNetherlands, Spain, Belgium, Japan, Finland, Chile, Australia, United States, Argentina, Canada, Czech Republic, Denmark, France, Germany, Hungary, Israel, Italy, Mexico, Norway, Poland, Portugal, Russian Federation, Slovakia, South Africa and more
-
MicroPort CRMCompletedAtrial ArrhythmiaUnited States, Germany, Spain, Denmark, Switzerland, France, Belgium, Australia, Japan, Italy, Canada, Netherlands
-
National Cerebral and Cardiovascular CenterRecruiting
-
International Registry of Asymptomatic Brugada...WithdrawnArrhythmiaNetherlands, Israel, United States, Japan, Germany, Italy
-
Fujita Health UniversityElixirgen Therapeutics, Inc.Completed
-
ModernaTX, Inc.CompletedCoronavirus Disease (COVID-19)Japan
-
TakedaWithdrawnSurvey of the Moderna COVID-19 Vaccine in People at High-Risk of Developing Severe COVID-19 SymptomsCoronavirus Disease (COVID-19)Japan
-
AstraZenecaActive, not recruitingCOVID-19, SARS-CoV-2Japan
-
Daiichi Sankyo Co., Ltd.CompletedAtrial FibrillationJapan
-
Kyoto University, Graduate School of MedicineCompleted
-
Boehringer IngelheimCompleted
-
Humanity & Health Medical Group LimitedTokyo University; Nihon University School of MedicineRecruiting
-
Boehringer IngelheimCompleted
-
Nagoya UniversityUnknown
-
PfizerCompleted
-
Biotronik Japan, Inc.Completed
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
Japan Cardiovascular Research FoundationUnknown
-
TakedaCompleted
-
PfizerCompletedNon-valvular Atrial FibrillationJapan
-
TakedaCompletedCoronavirus Disease (COVID-19)Japan
-
Medtronic Cardiac Rhythm and Heart FailureCompletedCongestive Heart Failure, Atrial Arrhythmia, Atrial Tachyarrhythmia, Atrial FibrillationGermany, Italy, United States, Spain, Denmark, Netherlands, Norway, Switzerland, Japan, Austria, Greece, United Kingdom
-
Bristol-Myers SquibbCompletedNon-Valvular Atrial Fibrillation (NVAF)Japan
-
Rohto Pharmaceutical Co., Ltd.CompletedSARS-CoV-2 Infection( COVID-19 )Japan
-
Bristol-Myers SquibbPfizerCompleted
-
Bristol-Myers SquibbCompletedAtrial FibrillationJapan
-
PfizerCompletedNon-valvular Atrial FibrillationJapan
-
PfizerCompleted
-
Boehringer IngelheimCompletedAtrial FibrillationJapan
-
BayerJanssen Scientific Affairs, LLCCompletedNon-valvular Atrial Fibrillation (NVAF)Japan
-
Ministry of Health, Labour and Welfare, JapanCompletedCoronary Disease | Atrial FibrillationJapan
-
Bristol-Myers SquibbPfizerCompletedNonValvular Atrial FibrillationJapan
-
Satoshi ShizutaDaiichi Sankyo Co., Ltd.; Research Institute for Production DevelopmentCompletedCoronary Artery Disease | Atrial FibrillationJapan
-
BayerCompleted
-
BayerCompletedEmbolism, Atrial Fibrillation and Venous ThrombosisJapan
-
Institute for Clinical Effectiveness, JapanActive, not recruitingPersistent Atrial Fibrillation | Catheter Ablation | Pulmonary Vein Isolation | Posterior Wall IsolationJapan
-
AstraZenecaCompleted
-
University of California, Los AngelesEnrolling by invitationVentricular Tachycardia | Cardiomyopathy | Ventricular Arrhythmia | Premature Ventricular Contraction (PVC)United States, Netherlands, Israel, Italy, Canada, Japan, Spain, United Kingdom
-
PfizerCompleted
-
AnGes, Inc.Japan Agency for Medical Research and DevelopmentCompleted
-
Daiichi Sankyo Co., Ltd.CompletedNon-valvular Atrial FibrillationJapan
-
Genova Inc.Tokyo Shinagawa HospitalRecruiting